Non-high-density lipoprotein cholesterol predicts nonfatal recurrent myocardial infarction in patients with ST segment elevation myocardial infarction

Abstract

BackgroundLipids, which are associated with atherogenesis, clotting, and the fibrinolytic pathway, may be important prognostic indicators of recurrent myocardial infarction. The aim of this study was to determine the predictive value of baseline lipid fractions for nonfatal recurrent myocardial infarction in patients with ST segment elevation myocardial infarction 2 years after primary percutaneous coronary intervention in China.MethodsCox proportional-hazards models were used to evaluate the association between potential risk factors, including lipid fractions, and the occurrence of nonfatal recurrent myocardial infarction in 2402 consecutive patients who underwent primary percutaneous coronary intervention for ST segment elevation myocardial infarction.ResultsThe cumulative incidence of recurrent myocardial infarction was 2.7% at 1 year, 3.8% at 2 years, and 5.8% at 3 years after percutaneous coronary intervention. The effects of collinearity of lipids were investigated. In concerning the principal components analysis, composing factor 1 (scoring factors were 0.689 for non-HDL, 0.702 for LDL, 0.182 for HDL) which had eigenvalues of 1.86 and explained 62% of the variability among lipid cholesterols was significantly associated with recurrent MI in the final adjusted analysis of the lipid cholesterols principal components. Non-high-density lipoprotein cholesterol was the strongest independent predictor of nonfatal recurrent myocardial infarction. The adjusted hazards ratios for nonfatal recurrent myocardial infarction were 1.26 (95% confidence interval (CI): 1.05–1.51) for non-high-density lipoprotein cholesterol, 1.17 (95% CI: 0.99–1.39) for low-density lipoprotein and 1.15 (95% CI: 0.95–1.40) for HDL. After adjusting for gender and age, the odds ratio for patients in the highest non-high-density lipoprotein cholesterol quartile was 2.10 (95% CI: 1.19–3.72).ConclusionsNon-high-density lipoprotein cholesterol value is a stronger predictor of nonfatal recurrent myocardial infarction than other lipid risk factors in patients with ST segment elevation myocardial infarction. Moreover, the occurrence of reinfarction after percutaneous coronary intervention was highest for patients in the highest non-high-density lipoprotein cholesterol quartile.Trial registration http://www.chictr.org.cn/edit.aspx?pid=13583&htm=4, registration number: ChiCTR-EPC-16008199, date of registration:2013.01.01.Electronic supplementary materialThe online version of this article (doi:10.1186/s12944-017-0418-5) contains supplementary material, which is available to authorized users.

Abacavir use and risk of recurrent myocardial infarction

“…Firstly, recurrent MIs in those with an index MI are more likely to reflect the uptake and success of post-MI interventions to manage CVD and prevent subsequent cardiovascular events in this group than differences in established risk factors for a primary MI. Our finding that few of the established CVD risk factors are associated with recurrent MI, other than diabetes, supports the existence of a different set of risk factors for recurrent MI, a notion which is consistent with the limited literature from the general population [13][14][15]. Secondly, one of the reasons for the continued debate about the potential association between ABC and MI is that there is no confirmed biological mechanism for the association.…”

Statins for atherosclerotic cardiovascular disease prevention in people living with HIV in Thailand: a cost‐effectiveness analysis

“…Since the risk score defines CVD as a composite of coronary intervention, MI, stroke (ischaemic or haemorrhagic) or other cardiovascular death, we apportioned the calculated risk into individual event types based on the proportions reported in Friis-Moller et al [24] Each individuals risk of non-CVD death was estimated by subtracting their calculated risk of CVD death from their age, sex and CD4 count specific risk of all-cause mortality [33]. Recurrent event probabilities (for example, the probability of a second MI or the probability of an MI after a prior ischaemic stroke) were mainly based on published estimates for the general population in high-income countries due to a lack of HIV-specific data or data from low-and middle-income countries; we did not use the D:A:D CVD risk score or a HIVspecific hazard ratio as current evidence suggests that risk factors for primary CVD differ substantially from those of recurrent CVD [34,[59][60][61]. Individuals accumulated costs and benefits up until their death or the time horizon, whichever came first.…”

Characterization of dysregulated lncRNA-mRNA network based on ceRNA hypothesis to reveal the occurrence and recurrence of myocardial infarction

“…Thus strategies for prediction of recurrent events will prolong survival in post-MI patients 4 . Non-high-density lipoprotein cholesterol value was recently found to be a strong predictor of recurrent MI 5 , and phospholipase A2 expression in coronary thrombus has been reported to be related with recurrence of cardiac events after MI 6 . Although some biochemical markers such as cardiac troponins T and I, creatine kinase-MB are clinically used for diagnosis of MI, they only indicate myocardial damage, and the molecular mechanisms underlying MI and recurrence of MI are not reflected.…”